Mechanisms of Thrombus Formation
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. Vessel-wall injury and the extravasation of blood from the circulation rapidly initiate events in the vessel wall and in blood that seal the breach. Circulating platelets are recruited to the site of injury, where they become a major component of the developing thrombus; blood coagulation, initiated by tissue factor, culminates in the generation of thrombin and fibrin. These events occur concomitantly (Figure 1A; also see Video, available with the full text of this article at www.nejm.org), and under normal conditions, regulatory mechanisms contain . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [35]
In the citing paper
“enhanced platelet reactivity and acute thrombotic occlusion of vessels are the proximate cause of myocardial infarction, stroke and the majority of deaths in patients with CVD36.”
From Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential (2018) · cites this paper as [36]
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
MACFARLANE, R. G. (1964) · Nature · doi:10.1038/202498a0 · Cited by 1,119
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
Esmon, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83649-3 · Cited by 1,046
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Research works printed but not linked: 4
- Semeraro N, 1983, Immunology, 50, 529
- Reinhardt C, 2008, J Clin Invest, 118, 1110
- Cho J, 2008, J Clin Invest, 118, 1123
- 1986, Lancet, 1, 397
Cited by
Items 601–700 of 1,000
Lo, R. W., Li, L., Pluthero, F. G., Leung, R., Eto, K., & Kahr, W. H. A. (2020) · Blood · doi:10.1182/blood.2019004276 · Cited by 31
Lv, K., Chen, S., Xu, X., Chiu, J., Wang, H. J., Han, Y., Yang, X., Bowley, S. R., Wang, H., Tang, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47493-0 · Cited by 33
“As part of the normal defense processes, the clotting system is rapidly initiated during hemostasis following vessel damage to seal the breach and sustain the integrity of a closed, high-pressure circulatory system 2 .”
Anti-Platelet Activity of Water Dispersible Curcuminoids in Rat Platelets
Anikisetty, M., Rao, L. J., & Naidu, K. A. (2015) · Phytotherapy Research · doi:10.1002/ptr.5274 · Cited by 29
Small GTPases in platelet membrane trafficking
Walsh, T. G., Li, Y., Wersäll, A., & Poole, A. W. (2018) · Platelets · doi:10.1080/09537104.2018.1535703 · Cited by 29
Gołaszewska, A., Misztal, T., Marcińczyk, N., Chabielska, E., & Rusak, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.657881 · Cited by 34
“However this study did not include elevated blood adrenaline while local generation of thrombin at a site of injury—in this particular model—is relatively high (Furie and Furie, 2008; Welsh et al., 2014; Shen et al., 2017).”
BackgroundAn Older Thrombus Delays Reperfusion after Mechanical Thrombectomy for Ischemic Stroke
Kitano, T., Hori, Y., Okazaki, S., Shimada, Y., Iwamoto, T., Kanki, H., Sugiyama, S., Sasaki, T., Nakamura, H., Oyama, N., et al. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1522-4507 · Cited by 29
Lyons, M. G., & Phalen, A. G. (2014) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000050 · Cited by 28
Zapponi, K. C. S., Mazetto, B. D. M., Bittar, L. F., Barnabé, A., Santiago-Bassora, F. D., Paula, E. V. D., Orsi, F. A., Franco‐Penteado, C. F., Conran, N., & Annichino‐Bizzacchi, J. M. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.01.035 · Cited by 30
“Thrombus formation is a multicellular process and develops on the surface of the endothelium, presenting a laminar structure consisting of platelets, leukocytes, erythrocytes and fibrin [20–23].”
BackgroundA Biologically Active Surface Enzyme Assembly that Attenuates Thrombus Formation
Qu, Z., Muthukrishnan, S., Urlam, M. K., Haller, C. A., Jordan, S. W., Kumar, V., Marzec, U. M., Elkasabi, Y. M., Lahann, J., Hanson, S. R., et al. (2011) · Advanced Functional Materials · doi:10.1002/adfm.201101687 · Cited by 28
Do galectins play a role in venous thrombosis? a review
Diaz, J. A., Ramacciotti, E., & Wakefield, T. W. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.11.011 · Cited by 33
“Circulating cell-derivedMP contribute to coagulation and the amplification of thrombosis [3].”
Discoidin Domains as Emerging Therapeutic Targets
Villoutreix, B. O., & Miteva, M. A. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.06.003 · Cited by 34
Profumo, E., Buttari, B., D’Arcangelo, D., Tinaburri, L., Dettori, M. A., Fabbri, D., Delogu, G., & Riganò, R. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1246485 · Cited by 28
“If the atherosclerotic lesion undergoes rupture, TF is released into the bloodstream [70, 71] and activates the coagulation pathway, thus promoting thrombotic events [72].”
BackgroundHemostasis in Overt and Subclinical Hyperthyroidism
Ordookhani, A., & Burman, K. D. (2017) · Intern J Endocrinol Metab · doi:10.5812/ijem.44157 · Cited by 32
“eration (secondary hemostasis) in one hand, and fibrinolytic system, on the other hand, to maintain vascular patency (1-6).”
BackgroundUpdate on pathological platelet activation in coronary thrombosis
Elia, E., Montecucco, F., Portincasa, P., Sahebkar, A., Mollazadeh, H., & Carbone, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27575 · Cited by 29
“Both PLTs and dysfunctional endothelial cells (ECs) contribute to the coronary thrombus formation by secreting protein disulfide isomerases (PDI; Furie & Furie, 2008).”
BackgroundmiR‐15a‐5p regulates expression of multiple proteins in the megakaryocyte GPVI signaling pathway
Basak, I., Bhatlekar, S., Manne, B. K., Stoller, M., Hugo, S. E., Kong, X., Ma, L., Rondina, M. T., Weyrich, A. S., Edelstein, L. C., et al. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14382 · Cited by 29
The importance of blood platelet lipid signaling in thrombosis and in sepsis
Bounes, F. V., Mujalli, A., Cénac, C., Séverin, S., Faouder, P. L., Chicanne, G., Gaits‐Iacovoni, F., Minville, V., Gratacap, M., & Payrastre, B. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.09.011 · Cited by 29
Casting A Wide Net On Surgery: The Central Role of Neutrophil Extracellular Traps
Eustache, J., Tohme, S. T., Milette, S., Rayes, R. F., Tsung, A., & Spicer, J. D. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003586 · Cited by 30
“This process culminates in the deposition of fibrin, trapping circulating cells and factors and resulting in vessel thrombosis.(41) NETs are intimately linked with many of these steps during the process, from initiation to propagation.”
BackgroundA Review of Venous Thromboembolism Risk Assessment and Prophylaxis in Plastic Surgery
Agrawal, N. A., Hillier, K., Kumar, R., Izaddoost, S. A., & Rohrich, R. J. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000008663 · Cited by 32
Adhar, M., HadjKacem, B., Périno, S., Amor, I. B., Feki, A., Gargouri, J., Gargouri, A. F., Tounsi, S., Chemat, F., & Allouche, N. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105858 · Cited by 27
Chen, D., Liu, Y., Liu, P., Zhou, Y., Jiang, L., Yuan, C., & Huang, M. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2083726 · Cited by 27
“Impairment of coagulation/fibrinolysis balance, changes in blood rheology, and damages to endothelial lining cause thrombosis, leading to serious cardiovascular diseases gradually (Furie & Furie, 2008).”
BackgroundSultana, N., Chung, H., Emon, N. U., Alam, S., Taki, M. T. I., Rudra, S., Tahamina, A., Alam, R., Ahmed, F., & Mamun, A. A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.911274 · Cited by 27
“Again, the thrombosis or formation of the blood clot is a result of summative cascade action where damaged regions of the endothelial cell surface or blood vessel are barricaded by the platelets deposition, tissue factor, and fibrin (52) where the foundational stage is governed by platelets when the activated platelet…”
BackgroundEffects of clopidogrel on the platelet activation response in horses
Brooks, M. B., Divers, T. J., Watts, A. E., Ness, S. L., Frye, A., Stokol, T., & Fubini, S. L. (2013) · American Journal of Veterinary Research · doi:10.2460/ajvr.74.9.1212 · Cited by 27
Novel Anti-platelet Agents: Focus on Thrombin Receptor Antagonists
Brito, F. D. S., & Tricoci, P. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9454-3 · Cited by 27
“It is also the most potent platelet activator, as it activates platelets at subnanomolar concentrations, while other agonists, such as ADP, require micromolar concentrations [8, 9].”
Ilinskaya, A. N., Man, S., Patri, A. K., Clogston, J. D., Crist, R. M., Cachau, R. E., McNeil, S. E., & Dobrovolskaia, M. A. (2013) · Nanomedicine · doi:10.2217/nnm.13.137 · Cited by 27
Zhao, J. W., Bai, L., Muhammad, K., Ren, X., Guo, J., Xia, S., Zhang, W., & Feng, Y. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00431 · Cited by 29
Analysis of platelet function: role of microfluidics and nanodevices
Santos-Martínez, M. J., Prina‐Mello, A., Medina, C., & Radomski, M. W. (2011) · The Analyst · doi:10.1039/c1an15445a · Cited by 26
Ahmad, I., Sharma, S., Gupta, N., Rashid, Q., Abid, M., Ashraf, M. Z., & Jairajpuri, M. A. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.07.048 · Cited by 26
Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease
Kanamori, F., Araki, Y., Yokoyama, K., U�da, K., Mamiya, T., Nishihori, M., Izumi, T., Okamoto, S., & Natsume, A. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-020-04668-0 · Cited by 26
Pillai, A. A., Kriss, M. S., Al‐Adra, D. P., Chadha, R., Cushing, M. M., Farsad, K., Fortune, B. E., Hess, A. S., Lewandowski, R. J., Nadim, M. K., et al. (2022) · Liver Transplantation · doi:10.1002/lt.26451 · Cited by 29
“Hemostasis is a dynamic process and occurs in three phases: primary hemostasis with primary platelet aggregation, secondary hemostasis with coagulation, and fibrinolysis.[4] The balance between the prohemostatic and antihemostatic factors during the normal physiological state is altered in patients with cirrhosis.”
BackgroundYe, J., Huang, F., Zeng, H., Xu, X., Wu, G., Tian, S., Zhao, J., & Zhang, W. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116092 · Cited by 26
Turrina, C., Schoenen, M., Milani, D., Klassen, A., Rojas‐González, D. M., Cvirn, G., Mela, P., Berensmeier, S., Slabu, I., & Schwaminger, S. P. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113428 · Cited by 26
Cao, W., Xie, S., Liu, Y., Ran, P., Zhang, Z., Fang, Q., & Li, X. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202312866 · Cited by 26
Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics
Samridhi, S., Setia, A., Mehata, A. K., Priya, V., Pradhan, A., Prasanna, P., Mohan, S., & Muthu, M. S. (2024) · Nanotheranostics · doi:10.7150/ntno.92184 · Cited by 28
“NIR-II fluorescence imaging with the electron acceptor 4,9-bis(5-bromothiophen-2-yl)-6,7-bis(4-(hexyloxy)phenyl)-[1,2 ,5]thiadiazolo[3,4-g] quinoxaline (TTQ) was achieved by utilizing a two-arm multifunctional telechelic glycopolymer.”
How I manage venous thromboembolism risk in hospitalized medical patients
Dobromirski, M., & Cohen, A. T. (2012) · Blood · doi:10.1182/blood-2012-03-378901 · Cited by 34
Molecular mechanisms for vascular complications of targeted cancer therapies
Gopal, S., Miller, K. B., & Jaffe, I. Z. (2016) · Clinical Science · doi:10.1042/cs20160246 · Cited by 27
Deng, J., Mei, H., Shi, W., Pang, Z., Zhang, B., Guo, T., Wang, H., Jiang, X., & Hu, Y. (2018) · Current Medical Science · doi:10.1007/s11596-018-1896-z · Cited by 26
AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.
Shariff, N., Aleem, A., Singh, M., Li, Y. Z., & Smith, S. J. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.649 · Cited by 35
Quantification of D-Dimer Levels in Human Saliva
Zhang, X., Wan, Y., Cooper-White, J. J., Dimeski, G., Atherton, J. J., & Punyadeera, C. (2013) · Bioanalysis · doi:10.4155/bio.13.190 · Cited by 26
Mavelli, G. V., & Kini, R. M. (2016) · Scientific Reports · doi:10.1038/srep32036 · Cited by 26
“= + + + I I 1/V Km/Vmax(1/[S]) (1 [ ]/Ki) 1/Vmax(1 [ ]/Ki) (2)”
Westall, G. P., Levvey, B. J., Salvaris, E. J., Gooi, J. H., Marasco, S., Rosenfeldt, F., Egan, C., McEgan, R., Mennen, M., Russell, P. A., et al. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.07.001 · Cited by 25
“vWF via an interaction with platelet GPIb, VI and Ib-V-IX induces thrombosis and platelet aggregation.(20) To date, the longest survival of a porcine–primate pulmonary xenotransplant has been achieved using lungs transplanted from a vWFdeficient pig that was also depleted of pulmonary vascular macrophages.”
BackgroundFang, C., & Schmaier, A. H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105096 · Cited by 25
“Arterial thrombus formation is a pathological process involving multiple components of the hemostatic system including platelets and other blood cells, blood coagulation and fi brinolytic proteins, and the vessel wall [1,2].”
Venous Thromboembolism in Sepsis: From Bench to Bedside
Galli, E., Maggio, E., & Pomero, F. (2022) · Biomedicines · doi:10.3390/biomedicines10071651 · Cited by 29
“The aggregation mechanism is further amplified by the platelet release of thromboxane A2 and adenosine diphosphate, acting on closer platelets through thromboxane receptors and P2Y12 receptors, and it is stabilized by αIIbβ3 receptors on the platelet surface [68], allowing the binding of vWF and fibrinogen to support…”
BackgroundRole of pyroptosis in hemostasis activation in sepsis
Zhu, C., Liang, Y., Luo, Y., & Ma, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1114917 · Cited by 27
“After the recruitment and activation stages, platelets firmly adhere to the vessel wall and promote continued platelet activation and aggregation, resulting in rapid thrombus growth (12).”
BackgroundInfluentialPlasma‐Derived Nanoclusters for Site‐Specific Multimodality Photo/Magnetic Thrombus Theranostics
Liu, C., Liu, M.-C. J., Jheng, P., Yu, J., Fan, Y., Liang, J., Hsiao, Y., Chiang, C., Bolouki, N., Lee, J., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301504 · Cited by 25
Roux, P. L., Robin, P., Delluc, A., Tardy, B., Abgral, R., Couturaud, F., Reffad, A., Gal, G. L., & Salaün, P. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.008 · Cited by 25
“Indeed, although still only partially understood, inflammation is an important mechanism of both venous thrombus formation and resolution, with an accumulation of inflammatory cells such as neutrophils andmacrophages within the thrombus and surrounding vein wall [7,8].”
BackgroundPhan, T. T. B., Ta, D. T., Nguyen, D. T. X., van den Broek, L. A. M., & Duong, G. T. H. (2011) · AMB Express · doi:10.1186/2191-0855-1-26 · Cited by 29
“In the physiological state, fibrin and platelets are utilized for clotting to prevent blood loss from injuries in a process called hemostasis (Furie and Furie 2008).”
BackgroundThe Future of Antiplatelet Therapy in Cardiovascular Disease
Patrono, C., & Rocca, B. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-020209-171035 · Cited by 26
Cho, E. H., Bauder, A. R., Centkowski, S., Shammas, R. L., Mundy, L. R., Kovach, S. J., Levin, L. S., & Hollenbeck, S. T. (2016) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000002893 · Cited by 25
Hasan, I., Hussain, M. S., Millat, M. S., Sen, N., Rahman, M. A., Rahman, M. A., Islam, S., & Moghal, M. M. R. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2017.03.005 · Cited by 25
Antic, D. A., Jelicic, J., Vuković, V., Nikolovski, S. S., & Mihaljević, B. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.10.002 · Cited by 25
Shu, G., Chen, Y., Liu, T., Ren, S., & Kong, Y. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-018-9677-x · Cited by 28
“Meanwhile coagulation cascade, which involves blood clotting factors, produces fibrin and thrombin to ensure thrombus stable (Davie et al. 1991; Furie and Furie 2008).”
BackgroundHawthorn, A. M., Bulmer, A. C., Mosawy, S., & Keogh, S. J. (2019) · The Journal of Vascular Access · doi:10.1177/1129729818820200 · Cited by 28
Proteomic analysis of calcium-enriched sol–gel biomaterials
Romero‐Gavilán, F., Araújo‐Gomes, N., Cerqueira, A., García‐Arnáez, I., Martínez‐Ramos, C., Azkargorta, M., Iloro, I., Elortza, F., Gurruchaga, M., Suay, J., et al. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01662-5 · Cited by 25
Platelet α‐granule cargo packaging and release are affected by the luminal proteoglycan, serglycin
Chanzu, H. A., Lykins, J. T., Wigna‐Kumar, S., Joshi, S., Pokrovskaya, I. D., Storrie, B., Pejler, G., Wood, J. P., & Whiteheart, S. W. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15243 · Cited by 25
Kremke, M., Hansen, M. K., Christensen, S., Tang, M., Andreasen, J. J., & Jakobsen, C.-J. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv297 · Cited by 25
“Both events create endothelial damage and inevitably lead to exposure of the thrombogenic subendothelial matrix, including the potent platelet activators collagen and tissue factor [16].”
BackgroundTian, X., Feng, M., Wei, X., Cheng, C., He, K., Jiang, T., He, B., & Gu, Z. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314349121 · Cited by 24
Emerging Targeted Delivery Strategies of Nanosystems for Ischemic Stroke Treatment
Ren, J., Ma, H., Yin, W.-J., Li, Y.-K., Lei, S.-Y., Liu, J., Yang, Y. R., & Guo, Z.-N. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s519328 · Cited by 25
“160 Thus, the thrombin-triggered release of rt-PA into the thrombus has great potential with a rapid response rate owing to its high sensitivity.”
Li, C., Zhang, X., Zhao, M., Wang, Y., Wu, J., Liu, J., Zheng, M., & Peng, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.027 · Cited by 24
Atherothrombotic risk in obesity
Vera, R. H., Vilahur, G., & Badimón, L. (2013) · Hämostaseologie · doi:10.5482/hamo-13-07-0034 · Cited by 27
“The coagulation and fibrinolytic systems are two separate but reciprocally linked enzyme cascades that regulate the formation and breakdown of fibrin (79).”
BackgroundGenetic and nongenetic factors influencing the response to clopidogrel
Notarangelo, M. F., Bontardelli, F., & Merlini, P. A. (2013) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328364bb04 · Cited by 24
Mahmud, S., Akhter, S., Rahman, M. A., Aklima, J., Akhter, S., Merry, S. R., Jubair, S. M. R., Dash, R., & Emran, T. B. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/782742 · Cited by 30
“Immunogenicity is another important issue which restricts the multiple treatments of a given patient with streptokinase [5].”
BackgroundFuture and upcoming non‐neoplastic applications of PET/CT imaging
Hashefi, M., & Curiel, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06082.x · Cited by 26
New Insights into Modulation of Thrombin Formation
Spronk, H. M. H., Borissoff, J. I., & Cate, H. T. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0363-3 · Cited by 25
“It also involves the generation of thrombin, facilitated by phospholipid surfaces provided by platelets and other cells, as well as microparticles released on cell activation [4].”
BackgroundReversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration
Levine, M., Swenson, S. D., McCormick, T. N., Henderson, S. O., Thomas, S. H., & Markland, F. S. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-012-0275-6 · Cited by 24
“is the stimulus for the activation of factor IX, resulting in a complex series of events which culminates in thrombin generation [4, 5].”
Aspirin resistance: Fact or fiction? A point of view
Mehta, J. L. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i9.280 · Cited by 24
Roessler, F. C., Ohlrich, M., Marxsen, J. H., Stellmacher, F., Sprenger, A., Dempfle, C.-E. H., & Seidel, G. (2011) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3283468a60 · Cited by 24
Li, Y., Nishikawa, T., & Kaneda, Y. (2016) · Scientific Reports · doi:10.1038/srep25077 · Cited by 24
Qian, Z., Wang, H., Tuo, X., Guo, H., Xu, P., Liu, D., Wei, Y., Liu, H., Fan, Y., & Guo, X. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00802c · Cited by 24
Mechanisms of blood coagulation in response to biomaterials: Extrinsic factors
Kalathottukaren, M. T., & Kizhakkedathu, J. N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100497-5.00003-3 · Cited by 31
Afroz, N., Hoq, M. A., Jahan, S., Islam, M. M., Ahmed, F., Shahid-Ud-Daula, A. F. M., & Hasanuzzaman, M. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e03112 · Cited by 24
“Very recently, deposition of platelets, tissue factor, and fibrin through thrombosis or blood clot formation block cell surface or blood vessels which become a troublesome event (Furie and Furie, 2008).”
BackgroundAltered microtubule equilibrium and impaired thrombus stability in mice lacking RanBP10
Meyer, I., Kunert, S., Schwiebert, S., Hagedorn, I., Italiano, J. E., Dütting, S., Nieswandt, B., Bachmann, S., & Schulze, H. (2012) · Blood · doi:10.1182/blood-2012-01-401737 · Cited by 24
Bioengineered in vitro models of thrombosis: methods and techniques
Zhang, Y. S., Oklu, R., & Albadawi, H. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.08.08 · Cited by 23
“Thrombosis is often the result of vascular injuries, featured by obstruction, to different degrees, of vascular lumens by coagulated blood and thus disturbance/cessation of blood flows at the site surrounding the thrombus (5,6).”
BackgroundMa, Z., Zhang, J., Zou, S., Huang, K., Li, W., Hilal, M. E., Zhu, M., Fu, Y., & Khoo, B. L. (2025) · ACS Nano · doi:10.1021/acsnano.4c09980 · Cited by 25
Transport of platelets induced by red blood cells based on mixture theory
Wu, W., Aubry, N., Massoudi, M., & Antaki, J. F. (2017) · International Journal of Engineering Science · doi:10.1016/j.ijengsci.2017.05.002 · Cited by 26
“Thrombosis in the coronary artery can lead to heart attacks; a thrombus can also be transported to the brain by blood circulation causing cardiogenic strokes (Furie & Furie, 2008; Handin, 2005).”
BackgroundAharon, A., Rebibo-Sabbah, A., Ben‐Shaul, S., Berkovich, H., Loven, D., Brenner, B., & Bar‐Sela, G. (2017) · Oncotarget · doi:10.18632/oncotarget.18792 · Cited by 23
“EVs also bear tissue factor (TF), the main activator of the coagulation cascade [10], and several anti-coagulant proteins, such as TF pathway inhibitor (TFPI) and endothelial protein C receptor (EPCR) [11].”
BackgroundPhosphoinositide 3-kinases in platelets, thrombosis and therapeutics
Ribes, A. M., Oprescu, A., Viaud, J., Hnia, K., Chicanne, G., Xuereb, J.-M., Séverin, S., Gratacap, M., & Payrastre, B. (2020) · Biochemical Journal · doi:10.1042/bcj20190402 · Cited by 23
Fabris, E., Korjian, S., Coller, B. S., ten Berg, J. M., Granger, C. B., Gibson, C. M., & Hof, A. W. J. V. ’. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1414-5009 · Cited by 24
Coagulation in Lymphatic System
Zhang, W., Li, J., Liang, J., Qi, X., Tian, J.-H., & Liu, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.762648 · Cited by 24
Thromboinflammation in Sepsis and Heparin: A Review of Literature and Pathophysiology
Vagionas, D., Papadakis, D., Politou, M., Koutsoukou, A., & Vasileiadis, I. (2022) · In Vivo · doi:10.21873/invivo.12991 · Cited by 24
Covid-19 vaccination and pregnancy: a systematic review of maternal and neonatal outcomes
Kontovazainitis, C.-G., Katsaras, G. Ν., Gialamprinou, D., & Mitsiakos, G. (2023) · Journal of Perinatal Medicine · doi:10.1515/jpm-2022-0463 · Cited by 29
“Thromboembolic events (both arterial and venous) were a composite outcome, including myocardial infarction, stroke, deep venous thrombosis, and pulmonary embolism (obstetrical) [29].”
BackgroundA Novel Synthesis of the Oxazolidinone Antithrombotic Agent Rivaroxaban
Yuan, J., Liu, K., Li, L., Yuan, Y., Liu, X., & Li, Y. (2014) · Molecules · doi:10.3390/molecules190914999 · Cited by 23
“Structures of rivaroxaban (1) and compounds 2–5.”
BackgroundMethodInfluentialDesign, Virtual Screening, and Synthesis of Antagonists of αIIbβ3 as Antiplatelet Agents
Полищук, П. Г., Samoylenko, G. V., Khristova, T. M., Krysko, O. L., Кабанова, Т. А., Kabanov, V. M., Kornylov, A. Y., Klimchuk, O., Langer, T., Andronati, S. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00865 · Cited by 24
Yari, M., Bitarafan, S., Broumand, M. A., Fazeli, Z., Rahimi, M., Ghaderian, S. M. H., Mirfakhraie, R., & Omrani, M. D. (2018) · PubMed Central · doi:10.22088/ijmcm.bums.7.1.1 · Cited by 24
“The seriousness of coronary atherosclerosis was further classified as a 1-, 2-or ≥3-vessel ailment as per the number of coronary vessels with critical stenosis (20, 21).”
BackgroundKurakula, K., Koenis, D. S., Herzik, M. A., Liu, Y., Craft, J. W., van Loenen, P. B., Vos, M., Tran, M. K., Versteeg, H. H., Goumans, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.183087 · Cited by 23
“Tissue Factor (TF), an integral cell-surface glycoprotein, is the initiator of the blood coagulation cascade and a key regulator of hemostasis.(1,2) Aberrant expression of TF”
BackgroundCollagen-induced thrombosis in murine arteries and veins
Cooley, B. C. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.019 · Cited by 23
“It can and has been speculated [17–21] that collagen, a highly thrombotic protein, is exposed and is a major thrombus-initiating element in at least some of these models, but clear evidence of collagen exposure is lacking.”
BackgroundZhang, Y., Xu, X., Shen, D., Song, J., Guo, M., & Yan, X. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.03.006 · Cited by 23
Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathies
Camous, L., Veyradier, A., Darmon, M., Galicier, L., Mariotte, É., Canet, E., Parquet, N., & Azoulay, É. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0851-4 · Cited by 23
“Newly produced platelets during recovery from thrombocytopenia have been demonstrated to be more susceptible to activation and coagulation initiation [6].”
BackgroundDVT: A New Era in Anticoagulant Therapy
Mackman, N., & Becker, R. C. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.203497 · Cited by 25
Adenosine A2Areceptor agonists with potent antiplatelet activity
Eduardo Fuentes, Q., Fuentes, M., Caballero, J., Palomo, I. F., Hinz, S., El‐Tayeb, A., & Müller, C. E. (2017) · Platelets · doi:10.1080/09537104.2017.1306043 · Cited by 23
“Recurrent atherothrombotic events in patients with CVD are essentially platelet activation-driven processes [34, 35].”
BackgroundGut microbiota-derived metabolites: Potential targets for cardiorenal syndrome
Lai, Y.-C., Zhu, Y., Zhang, X., Ding, S., Wang, F., Hao, J., Wang, Z., Shi, C., Xu, Y., Zheng, L., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107672 · Cited by 25
Brainard, B. M., Abed, J. M., & Koenig, A. (2011) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/1040638711407898 · Cited by 22
“The platelet cytoskeleton is responsible for platelet shape change and secretion of platelet granule contents.(8) The platelet granules contain procoagulant and proaggregatory substances that promote platelet recruitment and contribute to secondary hemostasis at sites of tissue injury.”
BackgroundHaemostatic Nanoparticles-Derived Bioactivity of from Selaginella tamariscina Carbonisata
Zhao, Y., Zhang, Y., Kong, H., Zhang, M., Cheng, J., Luo, J., Zhao, Y., & Qu, H. (2020) · Molecules · doi:10.3390/molecules25030446 · Cited by 22
“The normal physiological haemostasis and anticoagulation mechanism is a complex physiological and biochemical process mainly composed of three interrelated parts: vasoconstriction and platelet response, anticoagulation systems, and fibrinolysis systems [38].”
BackgroundFully automated platelet differential interference contrast image analysis via deep learning
Kempster, C., Butler, G., Kuznecova, E., Taylor, K. A., Kriek, N., Little, G., Sowa, M. A., Sage, T., Johnson, L. J., Gibbins, J. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08613-2 · Cited by 26
“However, there were significant differences when comparing washed platelets to ibrutinib treated platelets for manual annotators 2 and 4, suggesting that these annotators interpreted the images differently to the CNN and the other annotators (Supplemental Fig.”
MethodLi, Y., Tang, X., Chen, L., Xu, X., & Li, J. (2022) · Foods · doi:10.3390/foods11162403 · Cited by 23
“In cardiovascular disease, cerebral infarction, ischemic stroke, and myocardial infarction are all related to thrombus formed by fibrin and platelet coagulation, while thrombolytic drugs represented by urokinase, tissue plasminogen activator (t-PA), and streptokinase all have side effects such as severe bleeding or ga…”
BackgroundFibrin Adsorption on Cardiovascular Biomaterials and Medical Devices
Nzulumike, A. N. O., & Thormann, E. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c01057 · Cited by 22
Radu, C. M., Campello, E., Spiezia, L., Dhima, S., Visentin, S., Gavasso, S., Woodhams, B. J., Cosmi, E., & Simioni, P. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1052551 · Cited by 22
Ghosh, A., Banik, S., & Islam, M. A. (2015) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v10i4.23829 · Cited by 22
Use of Topical Hemostatic Agents in Gynecologic Surgery
Wysham, W. Z., Roque, D. R., & Soper, J. T. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000106 · Cited by 22
“An excellent summary of the clotting cascade can be found in a 2008 New England Journal of Medicine review.(2)”
BackgroundGuria, K. G., & Guria, G. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.12.014 · Cited by 22
“An unfading interest in the issues of blood coagulation is largely accounted for by the fact that disorders in the regulation of the blood aggregative state cause a range of severe pathologies that pose a threat to human health and life [3,4].”
BackgroundRisk of Thromboembolism in Patients with Immune Thrombocytopenia
(2015) · Journal of Hematology & Thromboembolic Diseases · doi:10.4172/2329-8790.1000185 · Cited by 22
“Monocyte MPs are an important sources of circulating tissue factor for arterial thrombus formation [25,27].”
Background
Metadata
- Authors
- Furie, B., & Furie, B. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Furie, Bruce
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-08-28
- Volume
- 359
- Issue
- 9
- Pages
- 938-949
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983760732
- Cited by
- 1,926
- References
- 122
- Citations by year
- 2026: 75 · 2025: 119 · 2024: 114 · 2023: 121 · 2022: 110 · 2021: 117 · 2020: 103 · 2019: 96 · 2018: 93 · 2017: 109 · 2016: 108 · 2015: 122 · 2014: 101 · 2013: 119 · 2012: 106
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL087203)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombus formation, hemostasis, platelet recruitment, coagulation, tissue factor, thrombin, fibrin, vascular injury, coagulation regulation
- MeSH terms
- Animals, Blood Coagulation, Blood Coagulation Disorders, Fibrinolytic Agents, Humans, Neoplasms, Thrombosis, Platelet Activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.